Replies to post #651307 on NorthWest Biotherapeutics Inc (NWBO)

[pgsd]

How the mighty have fallen, just two years ago $220 per share now only $11.56 The writing is on the wall as they well know.

"Novocure’s plan to reduce residual operating expenses by approximately $60 million includes a planned reduction in headcount of approximately 200 colleagues, 13% of its current workforce. Field-based commercial and field-based medical employees are minimally affected. Novocure expects to incur one-time costs related to the workforce reduction of approximately $7 million in the fourth quarter of 2023"

#dcvax #allsolidtumors $nwbo #gbm

How the might have fallen, just two years ago $220 per share. The writing is on the wall as they well know.

"Novocure’s plan to reduce residual operating expenses by approximately $60 million includes a planned reduction in headcount of…

— Peter Davis (@peter_brit) November 28, 2023

[The Danish Dude]

LOL NVCR management with another pump. Needs money for christmas. Look for insider trades. A lot of buys then a scam PR and then an Oups PR two days later with management having dumped before.

[CaptainObvious]

Wow. Something like this seemed inevitable eventually.

Might take a day for the real sh*t to hit the fan, sp wise